82 results
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
1 Apr 24
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to
7:15am
that is expected to have an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
13 Mar 24
Sol-Gel Reports Full-Year 2023 Financial Results and 2023 - Corporate Highlights and Recent Developments
8:34am
an improved safety profile compared to oral hedgehog inhibitors. Sol-Gel is conducting a Phase-3 clinical trial to investigate SGT-610 in approximately 140 … that is expected to have an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation
6-K
EX-99.1
2r4f5wo9hnq 5n5dmm
30 Nov 23
Current report (foreign)
7:10am
424B3
saxmq
12 May 23
Prospectus supplement
9:15am
6-K
EX-99.1
w7o0wu 7pgpflqtcr
12 May 23
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides
12:00am
6-K
EX-99.1
h4xsbtyitxsofc52d3ek
21 Nov 22
Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:42pm
6-K
EX-99.1
2kx 9uv0074
4 Aug 22
Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
9:32am
6-K
EX-99.1
hpx56wuuo5inxlqa
8 Jun 22
Current report (foreign)
7:15am
6-K
EX-99.1
dea7f06dej ra6q5p6
16 May 22
Current report (foreign)
7:35am
6-K
EX-99.1
snv dlidbv928
13 May 22
Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:05am
424B5
h7ir1t0
19 Apr 22
Prospectus supplement for primary offering
4:02pm
20-F/A
wwa58hl1gh77xb
7 Apr 22
Annual report (foreign) (amended)
4:06pm
6-K
EX-99.1
kdhztz6onphm
30 Mar 22
Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments
7:53am